Cleared Traditional

K852867 - HI-CHEM DIAGNOSTICS ENZYME RINSE CONCENTRATE

K852867 is an FDA 510(k) clearance for HI-CHEM DIAGNOSTICS ENZYME RINSE CONCEN..., manufactured by Hi Chem, Inc.. The device is a Class 1 Chemistry device with product code CKA cleared through the Traditional 510(k) pathway after a 52-day FDA review.

K852867 · Hi Chem, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1985
Decision
52d
Days
Class 1
Risk

K852867 is an FDA 510(k) clearance for the HI-CHEM DIAGNOSTICS ENZYME RINSE CONCENTRATE. Classified as Nadh Oxidation/nad Reduction, Alt/sgpt (product code CKA), Class I - General Controls.

Submitted by Hi Chem, Inc. (Brea, US). The FDA issued a Cleared decision on August 29, 1985 after a review of 52 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1030 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Hi Chem, Inc. devices

FDA 510(k) Submission Details - K852867

510(k) Number K852867 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 08, 1985
Decision Date August 29, 1985
Days to Decision 52 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
36d faster than avg
Panel avg: 88d · This submission: 52d
Pathway characteristics
Predicate-based equivalence.

CKA Device Classification - Class 1, General Controls

Product Code CKA Nadh Oxidation/nad Reduction, Alt/sgpt
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1030
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CKA Nadh Oxidation/nad Reduction, Alt/sgpt

All 117
Devices cleared under the same product code (CKA) and FDA review panel - the closest regulatory comparables to K852867.
GLUTAMIC PYRUVIC TRANSAMINASE, GPT(UV) REAGENT SET
K860110 · Technostics Intl. · Feb 1986
IN VITRO TEST DETERMINATION OF SGPT(ALT)
K854186 · Clinical Data, Inc. · Dec 1985
ALT(OPTIMIZED) REAGENT
K854502 · Sigma Diagnostics, Inc. · Nov 1985
ALT (ALANINE AMINO-THRANSFERASE)REAGENT
K851995 · Alpkem Corp. · May 1985
AMRESCO FLOW PAC SMA PHOSPHATE BUFFER CONCENTRATE
K851923 · Amresco, Inc. · May 1985
ROCHE REAGENT FOR ALT
K843111 · Roche Diagnostic Systems, Inc. · Oct 1984